• Product NamePropofol
• Brief DescriptionInhibitors
• Purification99.13%
• Biological ActivityPropofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
• Target NameGABA Receptor; Sodium Channel inhibitor
• CAS No. 2078-54-8
• Calculated MW 178.28
• Formulation C12H18O
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CC(C)C1=CC=CC(C(C)C)=C1O
  Pathways:Membrane transporter/Ion channel; Neuroscience
  Receptor:GABAR; Sodium Channel
  Boling pt:256C
  Melting pt:18C
  Solubility:Soluble in Water
  Appearance:Liquid
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Franks NP. Br J Pharmacol. 2006 Jan;147 Suppl 1:S72-81.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting